Improves 2025 expected GAAP operating expenses by $0.7 billion to a range of $5.2 – $5.4 billion Increases 2025 expected year-end cash balance by $0.5 billion – $1 billion to a range of $6.5 – $7.0 ...
CHICAGO--(BUSINESS WIRE)--Brainlab, a digital medical technology company, has announced United States Food and Drug Administration (FDA) 510(k) clearance and US launch for Spine Mixed Reality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results